Otis OTIS Q1 2026 Results Fall Short EPS 089 Revenue NA Wall Street Awaits Key Policy Announcement from Board of Investment Cal BanCorp BCAL Q1 2026 Earnings Why the Beat Matters Formula FORTY Trading at 14088 Key Decision Point 20260515 Quiet Luxury 2026s Top Silent SUVs Signal Shift in Auto Industry India Fuel Prices Rise Petrol Up 087 Diesel 091 CNG 1kg Amid Import Dependency Japan to Welcome First Crude Cargo via Strait of Hormuz Since Regional Conflict Escalated Endurance Technologies IPO Opens to Raise Rs 1162 Crore Credit Suisses Neelkanth Mishra Sees Scope for Meaningful Rate Cuts Anticipates Market PickUp from December URA Leverages Medtech Partnerships as It Prepares for IPO VZ Q1 2026 Earnings EPS Beats Estimates by 381 as Stock Eases Back on Mixed Signals QH Q4 2021 Earnings Massive EPS Miss Amidst Operational Challenges UAA Q1 2026 Earnings EPS Misses Estimates as Restructuring Costs Weigh on Results DTIL Q1 2026 Earnings EPS Miss and Steep SellOff as Losses Widen ALKS Q1 2026 Earnings EPS Surpasses Estimates Amid Revenue Disclosure Gap Stock Slips AKTS Q1 2026 Earnings PreRevenue Biotech Reports WiderThanExpected Loss Shares Edge Higher Janus Living Inc JAN Edges Lower Amid Consolidation Near Key Support Reviva Pharmaceuticals Holdings Inc RVPH Holds Steady at 041 as Key Levels Define Trading Range Occidental Petroleum OXY Gains Modestly as Support Holds Above Key Level Eaton Vance Municipal Income Trust EOT Advances 217 as TaxExempt Yield Appeal Drives Demand Aegon Funding Notes AEFC Hover Near Support Amidst Modest Gain BOX Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction RYZ Q1 2026 Earnings EPS Misses Estimates by 646 Amid Challenging Conditions Lite Strategy Inc LITS Q4 2024 Earnings Significant EPS Miss Signals Operational Challenges BSAC Q1 2026 Earnings EPS Surpasses Estimates Shares Rise 358 AAR Corp AIR Q1 2026 Earnings Strong EPS Beat Driven by Aftermarket Demand and Operational Discipline STZ Q1 2026 Earnings EPS Beats Estimates by 948 as Stock Edges Lower Anupam Rasayan India to Acquire Up to 742 Stake in Bliss GVS Pharma in Rs 1360 Crore Deal LGN Q1 2026 Earnings EPS Misses Estimates Despite Positive Market Reaction Ingles Markets Slides Amidst Sector Headwinds Key Support Levels in Focus